Skip to content
Home/Companies/Biotech/Ruby Bio
RB

Ruby Bio

Biotech·United States·Active·1yr hold

Ruby Bio is a biotech company, headquartered in United States.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Ruby Bio?

Ruby Bio is currently owned by Nucleus Capital through Nucleus Capital II (2024 vintage), since 2025.

Hand-verified · updated 2026-07-03

Nucleus Capital
Investor
Nucleus Capital
Nucleus Capital II · 2024 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Nucleus Capital II

Other portfolio companies in the same fund.

Bindbridge
Active
BiotechUnited Kingdom· 2026
Triple Bio
Active
BiotechNetherlands· 2026
AtmoCooling
Active
EnergyUnited States· 2025
Spark E-Fuels
Active
EnergyGermany· 2025
Telura
Active
EnergyGermany· 2025
Apoha
Active
Deep TechUnited Kingdom· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings